Diabetes drugs might someday be leveraged against pancreatic and prostate cancer cells, as a recent PET study from researchers at the University of California, Los Angeles (UCLA), has shed new light on how cancer cells import glucose.

A global association of imaging advocates is calling on the United Nations (UN) to make sure the value of medical technologies is reflected in the UN’s plans for sustainable development.

Konica Minolta Medical Imaging announced today new Blue Moon Lifecycle Solutions designed to help customers minimize downtime, maximize productivity, and eliminate risk throughout the lifetime of their hand held SONIMAGE P3 and portable SONIMAGE HS1 ultrasound systems.

While drug abuse can have a negative impact on both sexes, a newly published study has shown women’s brains might suffer more long-term effects from stimulant abuse than men. Neuroimaging has revealed that women who were previously dependent on stimulants demonstrate changes in brain structures involved with reward, learning and executive control.

Rivanna Medical has announced that Accuro, the company’s handheld ultrasound device, has received FDA 510(k) clearance and can now be marketed in the U.S.

PHS Technologies Group LLC, a division of PACSHealth, LLC, a developer of innovative software that records and analyzes ionizing radiation data from medical imaging procedures, announced today that it will integrate VirtualDose™CT software from Virtual Phantoms Inc. into their industry leading dose monitoring product DoseMonitor®.

Last week, a study published in JAMA Internal Medicine added fuel to the fire in the contentious debate surrounding overdiagnosis in mammography screening. As anyone who has followed this discussion in recent years might expect, there has been some pushback.

Supplemental MRI screenings of breast-cancer survivors are pricey and probably only worth the expense in subpopulations of women with certain clinical, biological and demographic characteristics. Further research is needed to define those parameters and, in the process, identify the women most likely to benefit.